Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.100
-0.030 (-0.73%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $185.39 million as of April 28, 2025. Its market cap has decreased by -69.29% in one year.
Market Cap
185.39M
Enterprise Value
118.98M
1-Year Change
-69.29%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $185.39M, a decrease of -76.73%. That is a compound annual growth rate of -19.83%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |